Last reviewed · How we verify
NCT07183033
Exploratory Trial of VR Intervention on Neuroplasticity in Older Adults With Cognitive Frailty
NA trial testing VR-Based Resistance Training Intervention in Cognitive Frailty in 15 participants. Enrolling by invitation.
30 November 2025
Quick facts
| Lead sponsor | Peking Union Medical College |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 21 July 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- VR-Based Resistance Training Intervention
- Standardized Leg-Raising Training
Conditions studied
- Cognitive Frailty — all drugs for Cognitive Frailty →
Sponsor
Peking Union Medical College
Who can join
60 and older, any sex, with Cognitive Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effects of VR based intervention on neuroplasticity in older adults with cognitive frailty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07183033
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Frailty
Currently open trials in the same condition.
- NCT07335978 — Chair Exercise and Intergenerational Activities in Older Adults With Physio-Cognitive Decline Syndrome · NA · active not recruiting
Other Peking Union Medical College trials
Trials by the same sponsor.
- NCT05917418 — Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk · NA · not yet recruiting
- NCT07261072 — Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS · Phase 4 · not yet recruiting
- NCT06026709 — Effectiveness and Cost-effectiveness of Digital Psychological Intervention (EmoEase) in Chinese COPD Patients · NA · not yet recruiting
- NCT07109765 — Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa · recruiting
- NCT07043192 — Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07183033 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07183033.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing